Idiopathic pneumonia syndrome following myeloablative chemotherapy and autologous transplantation

Annals of Pharmacotherapy

Volumn 35, Issue 2, 2001, Pages 196-201

  Bilgrami, Syed F A ^a   Metersky, Mark L ^a   McNally, Daniel ^a   Naqvi, Bilal H ^a   Kapur, Dinesh ^a   Raible, Donald ^a   Bona, Robert D ^a   Edwards, Richard L ^a   Feingold, Jay M ^a   Clive, Jonathan M ^a   Tutschka, Peter J ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Autologous stem cell transplant; Busulfan; Idiopathic pneumonia syndrome

Indexed keywords

BUSULFAN; GLUCOCORTICOID; MYELOABLATIVE AGENT;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CANCER; CANCER CHEMOTHERAPY; CELLULAR IMMUNITY; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; FEMALE; HUMAN; IDIOPATHIC DISEASE; INTERSTITIAL PNEUMONIA; LUNG ALVEOLITIS; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PERIPHERAL BLOOD STEM CELL; PNEUMONIA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SYNDROME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BUSULFAN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PNEUMONIA;

EID: 0035145482     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10071     Document Type: Article

References (32)

1. Pulmonary complications of bone marrow transplantation
2. Pulmonary complications of bone marrow transplantation
3. Idiopathic pneumonia syndrome after bone marrow transplantation
4. Clinical presentation, pathology and outcome of idiopathic pneumonia after marrow transplantation
5. Interstitial pneumonitis following autologous bone marrow transplantation
6. Nonbacterial nonfungal interstitial pneumonitis following autologous bone marrow transplantation in children treated with high-dose chemotherapy without total-body irradiation
7. Interstitial pneumonitis following autologous bone marrow transplantation
8. Acute and chronic pulmonary complications following autologous bone marrow transplantation in non-Hodgkin's lymphoma
9. Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy
10. Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: An analysis of four chemotherapy regimens
11. Pulmonary function after autologous bone marrow transplantation in children
12. Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia
13. Pulmonary function and complications subsequent to autologous bone marrow transplantation
14. High dose busulphan/cyclophosphamide for autologous bone marrow transplantation is associated with minimal non-hemopoietic toxicity
15. Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogeneic bone marrow transplantation
16. Long-term pulmonary sequelae after autologous bone marrow transplantation in children without total body irradiation
17. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: Toxicities and hematopoietic recovery
18. Idiopathic pneumonia syndrome. Changing spectrum of lung injury after marrow transplantation
19. A method for estimating the probability of adverse drug reactions
20. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients
21. Pulmonary complications in lymphoma patients treated with high-dose therapy and autologous bone marrow transplantation
22. Pulmonary dendritic cells: Sentinals of lung-associated lymphoid tissue
23. Control of type I collagen formation in the lung
24. Platelet-derived growth factor in idiopathic pulmonary fibrosis
25. Glucocorticoids affect human dendritic cell differentiation and maturation
26. Glucocorticoids modulation of human monocyte/macrophage function: Control of TNF-alpha secretion
27. Interstitial pulmonary fibrosis following busulfan therapy
28. The pulmonary toxicity of antineoplastic agents
29. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs
30. Busulfan-induced pneumopathy
31. Busulphan lung
32. Busulfan-induced pulmonary disease. Report of a case and review of the literature